Skip links

Chapter 3: Towards a Sustainable Future with BioSolve

Chapter 3: Towards a Sustainable Future with BioSolve – Exciting Developments Ahead!

We are thrilled to start 2024 on a high note and share the last instalment of our User Group Forum 2023 Blog with you.

This final post highlights the last half of the User Group Forum, which focused on “Towards a Sustainable Future with BioSolve – Sustainability and Beyond.” Our Managing Director and Founder, Andrew Sinclair, provided a compelling vision for the future of BioSolve, and we can’t wait to share all the exciting developments coming in 2024! Be sure to connect with us on LinkedIn to stay updated.

It’s worth noting that the BioSolve Process can already use multiple modalities, including MAB, Microbial, and Vaccine. Over the past 24 years, we’ve expanded our capabilities to include Pichia, mRNA, ADC, and more. We also analyse the basics, such as CoGs and Capital costs, NPV/NPC, Process Mass Intensity (PMI), and Scope 1 and 2 of Facility Sustainability evaluation.

At an open workshop with our users, we asked for feedback on what new features they’d find valuable. The top answer was data visualization and sustainability aspects – no surprise there! We’re already prototyping these features and are excited to share more as we move forward.

Our President and Founder, Andrew Sinclair, addressed what else we should consider as we look to the future. All we can say is that there are so many exciting developments happening! If you’re not already following us on LinkedIn, now is the time to check out our company page.

We’re optimistic and confident about the future of BioSolve and are ready to continue our thoughtful approach to sustainability and beyond. Thank you for joining us on this journey!